challenges in treating patients with tp53-mutated aml and future outlooks
Published 1 year ago • 1.6K plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
2:24
the challenges of treating tp53-mutated aml and mds
-
2:42
challenges in treating patients with tp53-mutated mcl & promising novel therapies being explored
-
1:13
the challenges of treating patients with mpns who possess a tp53 mutation
-
1:27
treatment options for patients with tp53-mutated aml
-
1:57
the benefit of allogeneic transplantation in patients with tp53-mutated aml
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
3:08
recent updates on tp53 mutation in cll
-
3:22
is tp53-mutated high-risk mds the same disease as tp53-mutated aml?
-
3:11
challenges in treating tp53-mutated aml, hope on the horizon
-
1:38
the importance of targeting tp53 in aml and agents being explored
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:40
outcomes of allohsct in tp53-mutated aml and mds
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
8:14
progress in the treatment of tp53 mutated aml
-
3:56
treatment approaches for patients with tp53-mutated mcl
-
1:57
tolerability and efficacy of magrolimab plus azacitidine in tp53-mutated aml patients
-
1:59
depth of molecular response in patients with tp53m mds & aml treated with magrolimab and azacitidine
-
2:23
improving treatment for patients with tp53-mutated myeloid malignancies
-
5:16
an analysis of tp53 mutation in aml and hr-mds
-
1:39
treatment approaches for patients with tp53m aml ineligible for high intensity chemotherapy
-
1:08
novel strategies to target p53-mutant hematological malignancies
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy